Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
This study has been completed.
Study NCT00460486 Information provided by Baxter Healthcare Corporation
First Received: April 13, 2007 Last Updated: March 27, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Encephalitis, Tick-Borne
Additional conditions recognized in this trial
Encephalitis
More general conditions related to this trial
Arbovirus Infections
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Encephalitis, Arbovirus
Encephalitis, Viral
Flaviviridae Infections
Flavivirus Infections
Nervous System Diseases
RNA Virus Infections
Tick-Borne Diseases
Virus Diseases
Additional drug interventions recognized in this trial
Formaldehyde
More general drug interventions related to this trial
Anti-Infective Agents
Disinfectants
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Baxter Healthcare Corporation
Back to top of Main Content